Brief: PAVmed Regains Compliance With Nasdaq Stockholders' Equity Requirement
18/02/2025 15:03
Feb 18 (Reuters) - Lucid Diagnostics Inc LUCD.O :
* PAVMED REGAINS COMPLIANCE WITH NASDAQ STOCKHOLDERS' EQUITY
REQUIREMENT
Source text: ID:nPn3lvNcFa
Further company coverage: LUCD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on PAVmed
See all newsBrief: Lucid Diagnostics Begins Receiving Medicare Reimbursement For Esoguard® And Closes $15 Million Financing
PAVmed Inc reports results for the quarter ended June 30 - Earnings Summary
PAVmed Inc expected to post a loss of 47 cents a share - Earnings Preview
NASDAQ RESUMED AT 11:36 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:21 AM